Biora Therapeutics

(OTC) BIORQ

Current Price$0.00

Market Cap$500.00

Since IPO (2020)-100%

5 Year-100%

1 Year-100%

1 Month+0%

Biora Therapeutics Financials at a Glance

Market Cap

$500.00

Revenue (TTM)

$1.76M

Net Income (TTM)

-$31.54M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

2.67 (High)

Dividend

$0.00

Beta (Volatility)

2.67 (High)

Price

$0.00

Volume

564

Open

$0.00

Price

$0.00

Volume

564

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.34

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

2.67 (High)

Price

$0.00

Volume

564

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.34

Estimated Earnings Date

Aug 11, 2026

BIORQ News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biora Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Adi Mohanty, MBA

Website

www.bioratherapeutics.com

Headquarters

San Diego, CA 92122, US

BIORQ Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-1678575.00%

Net Income Margin

-3102875.00%

Return on Equity

121.86%

Return on Capital

N/A

Return on Assets

-397.61%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$500.00

Shares Outstanding

4.52M

Volume

564

Avg. Volume

1.41K

Financials (TTM)

Gross Profit

$665.00K

Operating Income

-$60.87M

EBITDA

-$24.06M

Operating Cash Flow

-$5.37M

Capital Expenditure

-$280.00K

Free Cash Flow

-$5.50M

Cash & ST Invst.

$3.20M

Total Debt

$39.65M

Biora Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$32.00K

N/A

Gross Profit

$32.00K

+125.6%

Gross Margin

100.00%

N/A

Market Cap

$500.00

N/A

Market Cap/Employee

$8.62

N/A

Employees

N/A

Net Income

-$18.40M

+74.9%

EBITDA

-$16.23M

+77.1%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Total Cash

$3.20M

-74.6%

Total Debt

$39.65M

-51.9%

Accounts Receivable

$868.00K

+6.1%

Inventory

$0.00

N/A

Long Term Debt

$14.68M

-82.0%

Short Term Debt

$24.97M

+2495.1%

Return on Assets

-3.98%

N/A

Return on Invested Capital

2.11%

N/A

Free Cash Flow

$31.95M

+389.5%

Operating Cash Flow

$31.82M

+388.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MRZMMarizyme, Inc.

MRZMMarizyme, Inc.$0.00+0.00%

EDXCEndexx Corporation

EDXCEndexx Corporation$0.00+0.00%

BPTHBio-Path Holdings, Inc.

BPTHBio-Path Holdings, Inc.$0.04+0.00%

HALBHalberd Corporation

HALBHalberd Corporation$0.00+0.00%

EVFMEvofem Biosciences, Inc.

EVFMEvofem Biosciences, Inc.$0.01+7.14%

ISCOInternational Stem Cell Corporation

ISCOInternational Stem Cell Corporation$0.18+5.88%

ORGSOrgenesis Inc.

ORGSOrgenesis Inc.$0.40-19.19%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WENWendy's

WENWendy's$7.86+0.26%

AALAmerican Airlines Group

AALAmerican Airlines Group$17.44+0.08%

SOFISoFi Technologies

SOFISoFi Technologies$17.31+0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.87-0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.27+0.01%

PATHUiPath

PATHUiPath$10.31+0.01%

PFEPfizer

PFEPfizer$24.04-0.03%

Questions About BIORQ

What is the current price of Biora Therapeutics?

Biora Therapeutics is trading at $0.00 per share.

What is the 52-week range for Biora Therapeutics?

Over the past 52 weeks, Biora Therapeutics has traded between $0.00 and $0.34.

How much debt does Biora Therapeutics have?

As of the most recent reporting period, Biora Therapeutics reported total debt of $39.65M.

How much cash does Biora Therapeutics have on hand?

Biora Therapeutics reported $3.20M in cash and cash equivalents in its most recent financial results.

What is Biora Therapeutics’s dividend yield?

Biora Therapeutics does not currently have a dividend yield.

Biora Therapeutics

Biora Therapeutics Financials at a Glance

BIORQ News

Why Shares of Progenity Are Down More Than 11% on Wednesday

Why Progenity Stock Is Up More Than 34% Tuesday

Why Progenity Stock Was Up More Than 24% Friday

Why Progenity Stock Is Soaring on Tuesday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Biora Therapeutics

BIORQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Biora Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIORQ

What is the current price of Biora Therapeutics?

What is the 52-week range for Biora Therapeutics?

How much debt does Biora Therapeutics have?

How much cash does Biora Therapeutics have on hand?

What is Biora Therapeutics’s dividend yield?

Premium Investing Services